Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › Connecticut › Bridgeport
Qorannoo klinikaalii Kansara Qara'a Non-Small Cell Bridgeport, CT keessatti
Qorannoo 14 Kansara Qara'a Non-Small Cell f Bridgeport fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Namoota walitti qabaa jiraSadarkaa 3
- Stony Brook University Medical Center, Stony Brook · Miili 18 fagaatti
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Namoota walitti qabaa jiraSadarkaa 3
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · Miili 4 fagaatti
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · Miili 5 fagaatti
- Stony Brook University Medical Center, Stony Brook · Miili 18 fagaatti
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Smilow Cancer Hospital - Trumbull, Trumbull · Miili 4 fagaatti
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Namoota walitti qabaa jiraSadarkaa 3
- University Hospital at Stony Brook ( Site 0054), Stony Brook · Miili 18 fagaatti
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Stony Brook · Miili 18 fagaatti
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2/3
- Suny-Stony Brook University Cancer Center, Stony Brook · Miili 18 fagaatti
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Namoota walitti qabaa jiraSadarkaa 1
- New york cancer and blood specialists - Oncology, Port Jefferson Station · Miili 19 fagaatti
- New york cancer and blood specialists - Oncology, Port Jefferson Station · Miili 19 fagaatti
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Stony Brook University Medical Center, Stony Brook · Miili 18 fagaatti
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Port Jefferson Station · Miili 19 fagaatti
Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- Smilow Cancer Hospital Care Center - Trumbull, Trumbull · Miili 4 fagaatti
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · Miili 4 fagaatti
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · Miili 5 fagaatti
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · Miili 4 fagaatti
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · Miili 5 fagaatti
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2/3
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · Miili 4 fagaatti
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · Miili 5 fagaatti
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · Miili 4 fagaatti
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · Miili 5 fagaatti
Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti
- Houston, TXQorannoo 145
- New York City, NYQorannoo 121
- Arlington, VAQorannoo 104
- Nashville, TNQorannoo 97
- Boston, MAQorannoo 90
- Los Angeles, CAQorannoo 87
- St. Louis, MOQorannoo 73
- Chicago, ILQorannoo 61
- Baltimore, MDQorannoo 60
- San Antonio, TXQorannoo 59
- Columbus, OHQorannoo 57
- Washington, DCQorannoo 55
Qorannoo biroo Bridgeport keessatti
- Saree OljooQorannoo 21
- Dhibee QaraQorannoo 13
- Leukemia Myeloidii HamaaQorannoo 12
- Dhibee Onneessaa fi DhiigaQorannoo 9
- Saree (Gosoota Hunda)Qorannoo 8
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 8
- Kansara MetastatikiiQorannoo 7
- Cufama OnneeQorannoo 7
- Aneurysm SerebriiQorannoo 6
- Myeloma Baay’eeQorannoo 6
- Kansarii ProstateQorannoo 6
- Kansarii OvariiQorannoo 5
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.